Literature DB >> 7224593

Evidence for a "dying-back" gliopathy in demyelinating disease.

S K Ludwin, E S Johnson.   

Abstract

Recurrent demyelination was produced in mice by Cuprizone administration. During the second course of Cuprizone, the animals showed greater resistance to the toxin and demyelination occurred slowly and was complete only after prolonged periods. The earliest changes in oligodendrocytes occurred in the most distal processes, the inner cytoplasmic tongues, which showed degenerative changes 3 to 4 weeks before degeneration of the oligodendrocyte cell bodies or demyelination occurred. The results show for the first time that in demyelinating disease, a "dying-back" process similar to that described in axonal disease can affect the oligodendrocyte.

Entities:  

Mesh:

Year:  1981        PMID: 7224593     DOI: 10.1002/ana.410090316

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  29 in total

1.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

2.  CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.

Authors:  LiPing Liu; Abdelmadjid Belkadi; Lindsey Darnall; Taofang Hu; Caitlin Drescher; Anne C Cotleur; Dolly Padovani-Claudio; Tao He; Karen Choi; Thomas E Lane; Robert H Miller; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2010-02-14       Impact factor: 24.884

3.  Motor learning promotes remyelination via new and surviving oligodendrocytes.

Authors:  Clara M Bacmeister; Helena J Barr; Crystal R McClain; Michael A Thornton; Dailey Nettles; Cristin G Welle; Ethan G Hughes
Journal:  Nat Neurosci       Date:  2020-05-18       Impact factor: 24.884

4.  The demonstration of recurrent demyelination and remyelination of axons in the central nervous system.

Authors:  E S Johnson; S K Ludwin
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

5.  Biochemically altered myelin triggers autoimmune demyelination.

Authors:  Andrew V Caprariello; James A Rogers; Megan L Morgan; Vahid Hoghooghi; Jason R Plemel; Adam Koebel; Shigeki Tsutsui; Jeffrey F Dunn; Lakshmi P Kotra; Shalina S Ousman; V Wee Yong; Peter K Stys
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-04       Impact factor: 11.205

6.  Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.

Authors:  Rachel Barker; Dannielle Wellington; Margaret M Esiri; Seth Love
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-27       Impact factor: 6.200

Review 7.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Electrolyte-induced demyelination in rats. 2. Ultrastructural evolution.

Authors:  A M Rojiani; E S Cho; L Sharer; J W Prineas
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum.

Authors:  Angela Groebe; Tim Clarner; Werner Baumgartner; Jon Dang; Cordian Beyer; Markus Kipp
Journal:  Cerebellum       Date:  2009-03-04       Impact factor: 3.847

10.  Synchrotron X-ray fluorescence reveals abnormal metal distributions in brain and spinal cord in spinocerebellar ataxia: a case report.

Authors:  Bogdan F Gh Popescu; Christopher A Robinson; L Dean Chapman; Helen Nichol
Journal:  Cerebellum       Date:  2009-03-24       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.